Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$2.68 - $6.14 $362,604 - $830,742
135,300 New
135,300 $503,000
Q1 2022

May 13, 2022

SELL
$5.05 - $7.53 $87,183 - $129,997
-17,264 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.67 - $10.18 $97,886 - $175,747
17,264 New
17,264 $105,000
Q2 2021

Aug 12, 2021

SELL
$13.41 - $22.4 $257,472 - $430,080
-19,200 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$12.83 - $42.25 $246,336 - $811,200
19,200 New
19,200 $456,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.12B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.